← Back to timeline

2026-09-24M&A

Senti Biosciences Holdings, Inc. [SNTI] - reverse stock split proposal

Senti Biosciences Holdings, Inc. has filed a merger proxy to approve a reverse stock split of its common stock at a ratio ranging from 1-for-20 to 1-for-50, subject to board discretion.

View source filing ↗

Why this matters

Generating analysis…